Viral Fibrotic Scoring and Drug Screen Based on MAPK Activity Uncovers EGFR as a Key Regulator of COVID-19 Fibrosis

0
131
Researchers clustered 277 cell lines and revealed distinct COVID-19 transcriptomic signatures of the cells with similar phenotypes that defines their suitability for COVID-19 research.
[Scientific Reports]
Vagapova, E. R., Lebedev, T. D., & Prassolov, V. S. (2021). Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Scientific Reports, 11(1), 11234. https://doi.org/10.1038/s41598-021-90701-w Cite
Full Article